Evidence map›Paper›PMID 35384624›Full record

ArticleDigestive diseases and sciences2022

Iron Deficiency in Patients with Inflammatory Bowel Diseases: A Prospective Multicenter Cross-Sectional Study.

Laurent Peyrin-Biroulet, Guillaume Bouguen, David Laharie, Gauthier Pellet, Guillaume Savoye, Cyrielle Gilletta, Christophe Michiels, Anthony Buisson, Mathurin Fumery, Jean-Noël Trochu and 2 more

Open access · hybridAbstract readMulticenter Study
In one paragraph

Article in Digestive diseases and sciences, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 18 papers, 3 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
18citing papers in PubMed, 3 pooled it
4.3field-weighted citation impact, top 5% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

18 citing papers in PubMed, 3 syntheses or guidelines pooled it, 28 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Pooled it
  4. Trial
  5. Article
  6. Article
  7. Observational
  8. Article
  9. Article
  10. Review
  11. Review
  12. Article
  13. Article
  14. Role of iron deficiency anemia in inflammatory bowel disease.World journal of clinical pediatrics · 2024
    Article
  15. Article
  16. Article
  17. Article
  18. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors at 6 institutions in 1 country.

Laurent Peyrin-BirouletDepartment of Gastroenterology, University of Lorraine, CHRU-Nancy, 54000, Nancy, France.ORCID 0000-0003-2536-6618
Guillaume BouguenCIC1414, Institut NUMECAN (Nutrition Metabolism and Cancer), CHU Rennes, Univ Rennes, INSERM, 35000, Rennes, France.
David LaharieService d'Hépato-gastroentérologie et Oncologie Digestive, CHU de Bordeaux, Hôpital Haut-Lévêque, 33000, Bordeaux, France.
Gauthier PelletService d'Hépato-gastroentérologie et Oncologie Digestive, CHU de Bordeaux, Hôpital Haut-Lévêque, 33000, Bordeaux, France.
Guillaume SavoyeINSERM UMR1073, Université de Rouen, Hôpital Universitaire de Rouen, Rouen, France.
Cyrielle GillettaDepartment of Pancreatology and Gastroenterology, University Hospital of Toulouse Rangueil, 31059, Toulouse Cedex 9, France.
Christophe MichielsService d'Hepato-Gastro-Entérologie, CHU Dijon Bourgogne, Dijon, France.
Anthony BuissonService d'Hépato-Gastroentérologie, Université Clermont Auvergne, Inserm, 3iHP, CHU Clermont-Ferrand, Clermont-Ferrand, France.
Mathurin FumeryDepartment of Gastroenterology, University Hospital of Amiens, and Peritox, University of Picardie, Amiens, France.
Jean-Noël TrochuCHU de Nantes, Nantes, France.
Patrice CacoubDepartment of Internal Medicine and Clinical Immunology, Groupe Hospitalier Pitié-Salpêtrière, AP-HP, 83 Boulevard de l'Hôpital, 75651, Paris, Cedex 13, France. patrice.cacoub@aphp.fr.
CARENFER study group
Inserm · FRCentre Hospitalier Universitaire de Bordeaux · FRCHU Dijon Bourgogne · FRCentre Hospitalier Universitaire Amiens-Picardie · FRCentre Hospitalier Universitaire de Nantes · FRCentre Hospitalier Universitaire de Toulouse · FR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundIron deficiency (ID) is a frequent condition in patients with inflammatory bowel disease (IBD).

aimOur aim was to investigate the prevalence of ID in patients with IBD.

methodsThis was a prospective multicenter cross-sectional study conducted in 21 gastroenterology departments in France between January and March 2020. All adult patients with confirmed IBD who were admitted to the hospital were eligible for inclusion. ID was defined as ferritinemia ≤ 100 μg/L in patients with signs of inflammation (C-reactive protein (CRP) ≥ 5 mg/L) or ferritinemia < 30 μg/L in the absence of inflammation.

resultsIn total, 1036 IBD (685 Crohn's disease and 351 ulcerative colitis) patients (52.1% women) with a mean age of 41.8 ± 15.5 years were recruited. Approximately half of the patients (504, 51.1%) were in disease remission at the time of enrollment. Systematic monitoring of iron status was performed in 12/21 (57%) participating centers, including measurements of ferritin (12/12, 100%), hemoglobin (11/12, 92%), transferrin saturation (TSAT) (6/12, 50.0%), and serum iron (5/12, 42%). About one-fifth of the patients had been treated with intravenous iron (218, 21.0%), whereas only a small percentage received oral iron (36, 3.5%). ID occurred in 97 patients (23.7% CI 95% 19.8-28.1). Patients with moderate/severe IBD activity (OR: 3.66; CI 95% 24.4-61.2; p = 0.007) or concomitant anemia (OR: 3.66; CI 95% 1.97-6.78; p < 0.001) had an increased likelihood of having ID.

conclusionPatients with moderate/severe IBD activity or concomitant anemia are at increased risk of ID. Early detection and management of ID in patients with IBD is recommended.

Indexed as

AnemiaAnemia, Iron-DeficiencyColitis, UlcerativeInflammatory Bowel DiseasesIron DeficienciesAdultCross-Sectional StudiesFemaleHumansInflammationIronMaleMiddle AgedProspective StudiesIronCrohn’s diseaseInflammatory bowel diseaseIron deficiencyPrevalenceUlcerative colitis

Identifiers

PMID35384624
PMCPMC9652270
OpenAlexW4225695298

What Socratic holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.